The post-transcriptional addition of uridyl ribonucleotides to cytoplasmic RNA 3′ ends has recently been implicated in several key aspects of eukaryotic RNA biology, including mRNA turnover and regulation of the biogenesis and activity of microRNAs (miRNAs) [1] [2] [3] [4] [5] [6] [7] . In the biogenesis of let-7 tumor-suppressor miRNAs, the cytoplasmic terminal uridylyl transferase (TUTase) ZCCHC11 (also known as TUT4 or PUP-2) catalyzes the 3′ uridylation of cytoplasmic let-7 precursors (pre-miRNAs), which targets them for destruction 1,2,4 . Additionally, ZCCHC11-dependent uridylylation is important in the regulation of mature miRNAs 3 and replication-dependent histone mRNAs in human cells 6 . In the fission yeast S. pombe, the orthologous enzyme, caffeine-induced death-suppressor protein 1 (Cid1), uridylylates polyadenylated mRNAs and stimulates their decay 8, 9 . These enzymes belong to the same family as the nuclear poly(A) polymerase 10, 11 , but the structural basis for their RNA binding and UTP selectivity has not yet been described.
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The post-transcriptional addition of uridyl ribonucleotides to cytoplasmic RNA 3′ ends has recently been implicated in several key aspects of eukaryotic RNA biology, including mRNA turnover and regulation of the biogenesis and activity of microRNAs (miRNAs) [1] [2] [3] [4] [5] [6] [7] . In the biogenesis of let-7 tumor-suppressor miRNAs, the cytoplasmic terminal uridylyl transferase (TUTase) ZCCHC11 (also known as TUT4 or PUP-2) catalyzes the 3′ uridylation of cytoplasmic let-7 precursors (pre-miRNAs), which targets them for destruction 1,2,4 . Additionally, ZCCHC11-dependent uridylylation is important in the regulation of mature miRNAs 3 and replication-dependent histone mRNAs in human cells 6 . In the fission yeast S. pombe, the orthologous enzyme, caffeine-induced death-suppressor protein 1 (Cid1), uridylylates polyadenylated mRNAs and stimulates their decay 8, 9 . These enzymes belong to the same family as the nuclear poly(A) polymerase 10, 11 , but the structural basis for their RNA binding and UTP selectivity has not yet been described.
Cid1 is a 46-kDa protein containing two recognizable sequence motifs: a nucleotidyl transferase motif common to all members of the DNA polymerase β (Polβ) superfamily and a poly(A) polymerase (PAP)-associated motif. By contrast, ZCCHC11 is much larger (185 kDa), as it contains a duplication of both motifs found in Cid1 as well as three CCHC-type zinc-knuckle motifs (Supplementary Fig. 1 ). The C-terminal Cid1-homologous region in ZCCHC11 is catalytically active 3 , and it shows striking domain conservation ( Supplementary  Fig. 1b,c) . ZCCHC11 interacts with the RNA-binding protein Lin28 to associate stably with (and uridylylate) pre-miRNAs of the let-7 family 1,2,4 , and ZCCHC11 inhibition in Lin28A-expressing cancer cells resulted in tumor regression and suppression of invasiveness 12 .
No equivalent RNA-binding partner has been described for Cid1, which, in monomeric recombinant form, efficiently uridylylates RNA substrates in vitro 8 . Nevertheless, we reasoned that structural studies of Cid1 might provide an insight into the mode of action of ZCCHC11 while being substantially more straightforward than the direct study of the metazoan enzyme.
Here we report the crystal structure of Cid1 in two apo conformers and in complex with UTP. The architecture of the active site of Cid1 reveals a histidine residue crucial for the UTP selectivity of the enzyme, and a dramatic remodeling of the active site in transition between the two conformers suggests a mechanism for the clearance of uridylated product. Cid1 lacks a canonical RNA recognition motif, yet it efficiently binds RNA. The crystal structure reveals three basic patches of amino acid side chains on the surface that are noncontiguous in the primary sequence and that together form a high-affinity RNA-binding strip across the surface of the enzyme. This first structure of a cytoplasmic RNA uridylyl transferase opens the way to new avenues in anticancer drug design.
RESULTS

Structures of apo and UTP-bound Cid1
We crystallized a functional but slightly truncated variant of Cid1 (residues 33-405) termed tCid1 (ref. 8) in two crystal forms (apoI and apoII, space groups C2 and P2 1 2 1 2 1 ). In addition, a UTP-bound structure was obtained by soaking crystals of form I (space group C2) in UTP. The structures were determined by molecular replacement and refined to 3.2 Å, 2.6 Å and 3.0 Å for apo structures and the UTPbound structure, respectively (Table 1) .
a r t i c l e s
The structure of Cid1 reveals two globular domains (overall dimensions 60 Å × 40 Å × 40 Å) bordering a large catalytic cleft of approximately 15 Å × 32 Å × 18 Å, resulting in limited interfacial contacts (Fig. 1a,b) . The N-terminal domain (NTD) consists of a mixed five-stranded, twisted β-sheet (β1-β5) and four α-helices (αA-αD) sandwiched together to give a Polβ 'palm'-domain topology 13 , and it possesses the Mg 2+ -ion-coordinating catalytic triad of aspartate residues found in all members of the Polβ family (Fig. 1a) . In our crystal structure, we were unable to visualize a Mg 2+ ion despite its presence during the crystallization process; this probably reflects its sequestration by the mildly chelating citrate anions and DNA present in the crystallization condition. The C-terminal domain (CTD) shares structural homology with the central domain of PAP 10, 11 and the C-terminal domains of trypanosomal TUTases 14 , and it comprises α-helices (αF-αO) and two β-strands (β6-β7). We performed a structural phylogenetic analysis 15, 16 of the tCid1 structure with respect to other members of the Polβ superfamily ( Fig. 1c,d ; also see Online Methods and Supplementary Note). Of all the polymerase structures compared, Cid1 is most closely related to the last common ancestor, and it is placed on an evolutionary branch between the Polβ family and the remaining uridylyl transferases. The most notable difference between the apoI and UTP-bound states is the deployment of a Cid1-specific two-stranded antiparallel β-sheet that we denote the 'trapdoor' (Fig. 1a,b) , which extends over the catalytic cleft on one side but is too flexible to be seen in either the apoI or apoII crystal structure (Fig. 1e,f) . No analogous loop is present in Cid1 orthologs from other species, however (Supplementary Fig. 1 ). The oscillatory motion of the NTD, especially the movement of strands β1 and β3 (Fig. 1f) , determines whether or not the trapdoor is deployed. In the apo structures, and in two of the four molecules of the asymmetric unit (ASU) of the UTP-bound crystal structure, the conformation of the β1 and β3 strands is such that the β-trapdoor is sterically excluded. However, in two molecules of the ASU of the UTP-bound structure, the β1 and β3 strands are positioned so that the β-trapdoor can traverse the two domains and be held in place via contacts between the β1-β3 loop. Additionally, we observed a large sweeping motion of the NTD with respect to the CTD in the second crystal form of apo Cid1 (Fig. 1f) , which is discussed later.
Structural basis of UTP binding
On the basis of multiple sequence comparisons, we initially suspected that the uridine base selectivity in Cid1 would be analogous to that seen in trypanosomal TUTases 14 . The active site architecture reveals similar interactions that allow the selection of UTP at the sugar-base edge, most notably the simultaneous interaction between Asn171 and the pyrimidine carbonyl and the ribose 2′ OH (Fig. 2a) ; Asn171 is one of the only amino acid side chains in the active site to alter conformation on transition from the apo to the UTP-bound state. This interaction maintains the π-stacking interactions between the uracil base and the aromatic ring of Tyr212, and it allows the selection of ribose moieties over deoxyribose. Additionally, Phe88 is within van der Waals contact of the uridine ribose sugar moiety, and it is homologous to Phe100 of PAP 11 . As with other members of the Polβ family, the triphosphate moiety is coordinated by direct hydrogen-bonding with serines and lysines (Fig. 2a) . However, despite these similarities in the modality of UTP binding, we found that Cid1 employs a different mechanism for uridine base selectivity from that used by the trypanosomal TUTases. In the latter, an aspartate and a glutamate residue cluster around the N3 amine group of uracil and interact with uracil via a water molecule 14, 17 , and both residues are positionally conserved in Cid1 as Asp330 and Glu333. However, structural comparison of the Cid1 and trypanosomal TUTase active sites (Supplementary Fig. 2 ) reveals an additional histidine residue (His336) in Cid1 that has no equivalent in the trypanosomal enzymes, is clearly involved in uridine selection and is positioned in close proximity to, or in contact with, the pyrimidine ring. To test this hypothesis, we mutated His336 to alanine and found that it transformed the TUTase into PAP activity (Fig. 2b) . Such a change of nucleotide specificity, without loss of catalytic activity, was unexpected. Sequence alignments of the nucleotide recognition motif (NRM) 18 reveal conservation of this histidine residue in all three known human TUTases, including ZCCHC6 and ZCCHC11 (Fig. 2c) , suggesting that this mechanism of uracil identification is conserved between S. pombe and mammals, although it is absent from trypanosomal TUTases. Assessment of the UTP-bound crystal structure by MolProbity 19 suggests that His336 adopts two conformations, between which the imidazole ring is flipped by 180°, with each conformation equally represented in the ASU. In the apolike conformer the distance between the His336 imidazole ring and the uracil amine suggests that a single water molecule, structurally conserved in other TUTases (Fig. 2d) , is simultaneously coordinated by the Nδ1 of His336 and the uracil N3 amine. In the alternative conformer, the His336 imidazole amine (Nε2) is positioned toward the uracil carbonyl oxygen (O4) at a distance of 3.1 Å. The hydrogenbonding pattern observed in either mechanism is capable of discriminating uracil over other pyrimidines and other nucleotides. This redundancy suggests a 'fail-safe' mechanism for UTP discrimination. Thus the acquisition of His336 during evolution may have been sufficient to convert an ancestral PAP into the common ancestor of Cid1 and its human orthologs. The observation that the H336A mutant has PAP activity itself strongly supports this contention. The measured npg a r t i c l e s distances between His336, Asp330, the uridine N3 amine and a proposed modeled structural water molecule suggest ideal hydrogen bonding distances and a donor-acceptor system involving Asp330 that allows the detection of a uracil-specific amine 20 . Mutation of Asp330 to alanine reduced but did not ablate the TUTase activity (Fig. 2b) . This would be expected if Cid1 employs an additional uracil selection process using the flipped His336 conformer to detect the uracil-specific carbonyl. We therefore suggest that initial UTP binding involves Asp330, but the cross-checking state requires only His336. The deployment of the β-trapdoor correlated with the flipped conformation of His336 (Fig. 2a) , whereas in the UTP-bound state, where the β-trapdoor is not deployed, His336 adopts an apo-like conformation. It is possible that the trapdoor acts to prevent UTP from leaving the active site when His336 is flipped. This correlation suggests that subtle allosteric effects specific to the flipped His336 conformer cause β-trapdoor deployment, perhaps because they are an adaptation required for the carbonyl detection stage of uracil decoding.
In the trypanosomal TUTases, the protrusion of an NTD loop region into the active site and the specific presence of an arginine residue that contacts the 3′ RNA ribonucleotide (Arg121 in TbTUT4 17 ) are essential for substrate binding. Interestingly, in TbTUT4 and RET2 this arginine side chain forms a salt bridge with a glutamate residue (Glu300 and Glu424 in TbTUT4 and RET2, respectively) that has been suggested to provide structural support for the NRM 20 . The presence of this salt bridge in the trypanosomal TUTases elevates the NRM by ~1 Å compared to that of Cid1. As a result, Cid1 Glu333, despite being equivalent to Glu300 and Glu424 in the trypanosomal enzymes, is further from the uridine base and is consequently unable to function analogously. Mutation of Glu333 to alanine in Cid1 resulted in greatly diminished TUTase activity (Fig. 2b) . It is possible that Glu333 contacts the 3′ RNA ribonucleotide, stabilizing a triple-stacked sandwich of Tyr121-UTP-3′ ribonucleotide for efficient transfer 17 .
Structural basis of RNA binding
Unlike other members of the Polβ superfamily, such as the noncanonical PAP Trf4 (refs. 21-23), Cid1 has not been found in a stable multiprotein complex with RNA-binding proteins, and, unlike canonical PAPs, Cid1 lacks an RNA recognition motif (RRM; Supplementary Fig. 1) . Nonetheless, electrophoretic mobility shift assays (EMSAs) showed that purified recombinant Cid1 bound RNA (Fig. 3a) , with no apparent sequence specificity (Supplementary Fig. 3a) . Cid1 must therefore contain a cryptic Figure 1 The crystal structure of tCid1. (a) The N-terminal (blue) and C-terminal (green) domains border the central catalytic cleft where UTP is bound. A Cid1-specific two-stranded β-sheet denoted as the trapdoor (red) extends from the CTD to the NTD only in the UTP-bound form. The NTD side of the catalytic cleft houses three aspartate residues essential for catalytic activity (orange 15 and displayed in the same orientation as the tCid1 structure in a. The electrostatic surface potential of tCid1 revealed several prominent positively charged patches (Fig. 3b) . To investigate the involvement of these regions in RNA binding, we mutated several of the basic amino acids to alanines and examined the effect on RNA binding and TUTase activity in vitro. EMSAs showed that double mutations within any one patch (K133A R137A, mutant 1; K321A R323A, mutant 2; R277A K282A, mutant 3) still allowed RNA binding (Fig. 3c) . 
r t i c l e s
However, combinations of double mutations in two regions were more disruptive; tCid1 doubly defective in regions 2 and 3 lacked any RNA binding detectable by EMSA (Fig. 3c and Supplementary Fig. 3b ).
All the mutant proteins impaired in RNA binding showed defective TUTase activity (Fig. 3d) ; in contrast, the inactive tCid1DADA mutant, lacking two aspartates in the catalytic triad 24 , showed unimpaired RNA binding. The approximate RNA length that the putative RNA-binding surface is capable of accommodating was estimated using the singlestranded RNA from the poly(A)-binding protein crystal structure 25 (PDB1CVJ) and it suggests that Cid1 is capable of binding to a singlestranded RNA molecule of ~13 nucleotides. This is similar in length to the minimal oligonucleotide length (15 nucleotides) observed in EMSA experiments (Supplementary Fig. 3c ).
The RNA-binding characteristics of tCid1 and its mutant derivatives were characterized in detail by surface plasmon resonance (SPR; Supplementary Figs. 4 and 5) . Wild-type tCid1 showed tight RNA binding with surprisingly high on-and off-rate constants, which complicated estimation of a K d from kinetic measurements. Steadystate SPR analyses gave higher apparent K d values ( Supplementary  Fig. 5 ) of approximately 100 nM for tCid1, 200 nM for mutant 1, 450 nM for mutant 2 and 410 nM for mutant 3. Scatchard plots for tCid1 and mutants 1 and 2 were nonlinear and concave (Fig. 3e) , consistent with heterogeneous binding at more than one subsite. The plot for mutant 3 was almost linear with a shallow curvature, indicating binding dependent on a single site. We therefore propose that RNA binding by Cid1 involves two sites, the first depending on regions 1 and 2 and the second depending on region 3.
Substrate recognition and product ejection by Cid1
Altogether, our data suggest that Cid1 has a two-stage RNA recognition mechanism, in which its general RNA-binding ability is succeeded by specific binding of the 3′ end alongside UTP. The bound RNA could be threaded along the basic groove on the surface of Cid1 and fed into the active site cleft (Fig. 3b) before uridylylation. This mode of RNA binding is distinct from that used by trypanosomal TUTases, canonical PAPs and PAPD1, a human noncanonical PAP 26 . The latter lacks the RRM found in canonical PAPs but does possess an N-terminal region similar to RNP-type RNA-binding domains.
The apoII crystal structure of Cid1 obtained at higher resolution contained two molecules of Cid1 in the asymmetric unit, with radically different conformations (Fig. 1f) . Domain-movement analysis of the two structures, using DynDom 27 , revealed that the NTD (residues 31-164) rotates by 42° about Asn166 with respect to the CTD, and it also translates by 5Å (Fig. 1f) . Animation of the conformational change between apo conformers I and II (Supplementary Videos 1 and 2) indicates a sweeping motion that brings the NTD down into the UTP-binding region of the active site cleft. We propose that this movement is responsible for the ejection of uridylated products before the resumption of an open (apoI conformer) structure and a new round of RNA binding and uridylation.
DISCUSSION
We have described how tCid1 adopts two different apo conformers-one primed for substrate binding, the other engaged in product ejection. The UTP-bound state that intervenes demonstrates a previously undescribed mechanism of uracil discrimination dependent on His336 (Fig. 2) . Electrostatic and mutational analyses have shown how RNA substrates of tCid1 traverse the surface of the enzyme via a series of basic patches (Fig. 3) , enabling feeding of the substrates into the active site where 3′ uridylation occurs. Given that, like Cid1, numerous other members of the Polβ nucleotidyltransferase superfamily lack recognizable RNA-binding modules, this previously undescribed mode of RNA binding may be more widespread, although the extent will only be revealed by further structural studies. The RNA-class specificity of the human orthologs of Cid1 presumably reflects their acquisition of additional structural elements (such as zinc knuckles) as well as their interaction with substrate-specific RNA-binding proteins such as Lin28A.
Perhaps the most striking finding of our study is, however, the histidine dependence of uracil selection. This critical residue, His336, is conserved in the mammalian TUTases (Fig. 2c and  Supplementary Fig. 1b) but is absent from the trypanosomal enzymes, providing further evidence for the functional and structural homology between ZCCHC6, ZCCHC11 and Cid1 (ref. 8) . Inhibition of ZCCHC11 expression was recently shown to suppress cancer-related phenotypes including invasion and metastasis in human cell lines and xenografts 12 . The identification of His336-dependent nucleotide selectivity in Cid1 thus provides a rationale for the identification of selective small-molecule inhibitors of mammalian TUTases, on the one hand, and of trypanosomal TUTases on the other. The insights afforded by this study into the basis of catalysis by Cid1 open up the possibility of using this structural information to target TUTase enzymes therapeutically in both cancer and trypanosomiases.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. The structures reported in this manuscript have been deposited in the Protein Data Bank, with accession codes 4E7X (crystal form I, apoI conformer), 4E80 (UTP-bound) and 4E8F (crystal form II containing apoII conformer).
Note: Supplementary information is available in the online version of the paper.
ONLINE METHODS
Expression and purification of tCid1. S. pombe tCid1 was cloned as described previously 8 , expressed in E. coli BL21(DE3) pLysS (Novagen) and purified by glutathione, and then heparin, affinity chromatography. See Supplementary Note for more details. tCid1 crystallization. Purified tCid1 (in 20 mM HEPES, pH 7.0, 50 mM NaCl, 1 mM dithiothreitol) was crystallized in two crystal forms using nanoliter sittingdrop vapor diffusion. A UTP-bound complex was obtained by soaking crystals in 10 mM UTP. See Supplementary Note for more details.
Data collection. X-ray diffraction data from the two forms of native tCid1 crystals together with the UTP soaked crystals were collected under cryotemperature (~100 K) conditions using single-wavelength synchrotron radiation at Diamond Light Source (Didcot, UK). Owing to the marked difference in crystal size, diffraction data were collected using two different beamlines. In the case of the thin, plate-like crystals, the specialized microfocus beamline I24 was used for data collection of native and UTP-soaked crystals. Data collection was performed by collecting several consecutive wedges of data from adjacent positions within a single mounted crystal, using a beam size of 10 µm × 10 µm. In the case of the large crystals, the standard macromolecular crystallography beamline I04 was used for data collection.
The thin, plate-like crystals were radiation sensitive, and therefore the sweeps of data were initially processed with XDS 28 and SCALA 29 implemented in Xia2 30 . The subsequent merging statistics were used to create an optimized subset of data to be merged. Optimal data sets comprised a total of ≥90° of diffraction data from three to four positions on the mounted crystal. Data from each sweep were combined, merged and scaled in Xia2 30 to give a final working data set for the native state at a resolution of 3.2 Å and for the UTP-soaked state at a resolution of 3.0 Å, the statistics of which are summarized in Table 1 . In the case of the large crystals, several complete data sets to ~ 2.6 Å were collected from a single frozen crystal at adjacent positions within the mounted crystal. Each data set was indexed and integrated in MOSFLM 31 and merged and scaled using the CCP4 program SCALA 29 .
The two crystal morphologies belonged to different space groups; C2 (thin, plate-like crystals) and P2 1 2 1 2 1 (large, rod-like crystals), which were denoted as crystal form I and crystal form II, respectively (summarized in Table 1 ). tCid1 and UTP complex structure determination, model building and refinement. The structure of tCid1 was determined by molecular replacement using multiple search models, terminal uridylyl transferase 4 (ref. 17, PDB 2Q0E) and RET2 (ref. 20, PDB 2B4V) without its middle domain, in Phaser 32 . Both TUTases are from T. brucei, and both provided marginal solutions. The PDB ID 2Q0E search-model solution gave an R free of 49% after rigid-body refinement. This relatively high R factor was due to low sequence identity (21%) and conformational differences between Cid1 and the adopted search model. Therefore, the marginal solution was subjected to positional and B-factor refinement with autoNCS and targeted against the trimmed version of the search model, as generated by Chainsaw 33 and using local similarity symmetry restraints in autoBUSTER-TNT 34 . As a result, the R free decreased to 39%. The phase distribution obtained from this protocol was subjected to four-fold NCS averaging, histogram matching and solvent flattening as implemented in Parrot 35 . The resulting map allowed the automatic building of nearly 80% of the tCid1 model by Buccaneer 36 .
Model building of the apo (crystal form I) tCid1 structure was performed in COOT 37 , and a complete apoI model was refined to 3.2 Å using four-fold NCS restraints and individual B-factor refinement in autoBUSTER 34 . Final refinement using translation-libration-screw (TLS) 38 with a single TLS group per chain yielded a final R work and R free of 17.9% and 21.3%, respectively. Protein model geometry was assessed during rounds of model building and refinement using MolProbity 19 , which scored the model in the one-hundredth percentile against structures of equivalent resolution 19 . The Ramachandran plot as determined by MolProbity shows 98.6% of all residues in favored regions and 100% of all residues in allowed regions. The apoI crystal structure was used in a rigid-body refinement against the data set for the UTP-bound state. Unbiased electron density (F c -F o ) for a single UTP molecule per chain was clearly visible (Supplementary Fig. 2) . Coordinates for the UTP molecules were taken from the HIC-Up database 39 and were fitted in the electron density in COOT 37 . Refinement to 3.0 Å was performed in autoBUSTER-TNT 34 analogously to the apo crystal structures and yielded a final R work and R free of 17.6% and 20.1%, respectively. The Ramachandran plot for the UTP complex was determined by MolProbity and shows 98.2% of all residues in favored regions and 100% in allowed regions. MolProbity also scored this structure in the hundredth percentile. The apoII (second crystal form) was solved by Phaser 32 using the apoI refined structure. Positional and individual B-factor refinement of the apoII crystal structure was performed using auto-BUSTER-TNT 34 using two-fold NCS restraints and TLS with six groups per chain, determined by TLSMD 38 . The model was refined to 2.6 Å, yielding a final R work and R free of 19.3% and 23.7%, respectively. Final data collection and refinement statistics are given in Table 1 .
The structures encompass residues 41-380 of Cid1 according to the UniProt Accession code O13833. In all three structures, a flexible loop in the N-terminal domain between αD and β3 was not built, due to weak electron density.
Structural analysis. Domain motion between apoI and apoII structures was analyzed using the DynDom web server (http://fizz.cmp.uea.ac.uk/dyndom/) 27 . Phylogenetic analysis made use of the structure database web server DALI 40 before superimposition using SHP 15, 16 and comparison using Chimera 41 . Full details are given in Supplementary Note and Supplementary Tables 1 and 2 .
Plasmids. tCid1 mutants were generated by PCR-based site-directed mutagenesis using Pfu Turbo DNA polymerase (Stratagene) and pGEX6P-1 tCid1 (ref. 8) as a template. The oligonucleotides used for mutagenesis are listed in Supplementary  Table 3 . The combination of mutation sites was generated by successive sitedirected mutagenesis procedures on previously mutagenized templates. All constructs were verified by sequencing. See Supplementary Note for more details.
EMSA. Binding assays were carried out in 10 µl. 10,000-30,000 c.p.m. of 5′-end-labeled RNA (corresponding to approximately 0.2 pmol) were boiled for 1 min and subsequently incubated for 2 min on ice. 5× buffer was added to yield final concentrations of 20 mM Tris HCl, pH 8, 150 mM KCl, 2 mM MgCl 2 , 2.5 mM dithiothreitol, 100 µg ml −1 BSA, 5% glycerol. The indicated amounts of proteins were added in 1 µl. Binding reactions were incubated at room temperature for 5 min or on ice for 15 min and then loaded on a nondenaturing Trisglycine (25 mM-250 mM) 5% polyacrylamide gel, prerun for 15 min. Gels were run for 80 min at 170 V (10 V cm −1 ), dried and exposed to a storage phosphor screen. Screens were scanned with a Fuji FLA-5000 PhosphorImager, and results were analyzed with AIDA software. Oligonucleotides used for EMSA are listed in Supplementary Table 4 .
In vitro RNA nucleotidyl transferase assays. Polymerization reactions were set up as with the binding reactions except that UTP, or when appropriate CTP, GTP or ATP, was added to 0.5 mM. Reactions were incubated for 15 min at room temperature and stopped by adding 20 µl of STOP buffer (20 mM Tris-Cl, pH 7.5, 0.1 M NaCl, 10 mM EDTA). The RNA was ethanol precipitated, and pellets were resuspended in 6 µl of 8 M urea loading buffer and separated by 8 M urea 8% PAGE. Gels were run for 80 min at 40 W, dried and exposed to a storage phosphor screen.
SPR. SPR experiments were carried out using a Biacore 3000 (GE Healthcare). The 21-nucleotide RNA (5′-GAUUUGACGUUGGUUUUGACG-3′) was chemically synthesized with a 5′ biotin tag. Biotinylated RNA was immobilized to a CM5 sensor chip (GE Healthcare) indirectly by covalently coupled streptavidin at various levels (30 RU and 60 RU). Flow cells 1 and 3 were kept as control surfaces to account for nonspecific binding.
All experiments were performed at 22 °C using a flow rate of 50 µl min −1 in HBS-EP buffer (0.01 M HEPES, pH 7.4, 0.15 M NaCl, 0.005% Surfactant P20). The proteins were injected for 2 min at concentrations of 0.91, 2.74, 8.23, 24.69, 74.07, 222.22, 666.67 and 2,000 nM (and 50 and 100 nM for tCid1 and K133A R137A). Analysis at each protein concentration was repeated at least twice, and samples were run first increasing the concentrations and then decreasing them. Any protein that remained bound after a 2-min dissociation phase was removed by injecting 2 M NaCl for 60 s at 20 µl min −1 , which regenerated the RNA surface completely. The data were analyzed using BIAevaluation 3.0 (GE Healthcare). Background signal from a streptavidin-only reference flow cell was subtracted from every data set, as well as an average blank buffer injection. Kinetics data were npg
